Oscar Health (NYSE:OSCR) Shares Up 4.5%

Oscar Health, Inc. (NYSE:OSCR)’s share price shot up 4.5% during mid-day trading on Tuesday . The stock traded as high as $15.52 and last traded at $15.47. 863,308 shares changed hands during trading, a decline of 73% from the average session volume of 3,184,488 shares. The stock had previously closed at $14.80.

Analysts Set New Price Targets

Several research firms have recently issued reports on OSCR. The Goldman Sachs Group lifted their price objective on shares of Oscar Health from $8.00 to $16.00 and gave the company a “neutral” rating in a research report on Friday, February 9th. Raymond James began coverage on shares of Oscar Health in a research report on Friday, March 22nd. They set an “outperform” rating and a $20.00 price objective on the stock. Wells Fargo & Company lifted their price objective on shares of Oscar Health from $12.00 to $20.00 and gave the company an “overweight” rating in a research report on Thursday, February 15th. Finally, TheStreet raised shares of Oscar Health from a “d” rating to a “c-” rating in a report on Wednesday, February 21st. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, Oscar Health presently has an average rating of “Moderate Buy” and an average target price of $13.50.

Oscar Health Stock Down 0.9 %

The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.19 and a current ratio of 1.19. The firm’s 50 day simple moving average is $15.29 and its 200 day simple moving average is $10.71.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Wednesday, February 7th. The company reported ($0.66) EPS for the quarter, topping the consensus estimate of ($0.74) by $0.08. The company had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.43 billion. Oscar Health had a negative net margin of 4.62% and a negative return on equity of 29.99%. Oscar Health’s quarterly revenue was up 43.9% compared to the same quarter last year. During the same period in the previous year, the firm earned ($1.05) earnings per share. Analysts predict that Oscar Health, Inc. will post -0.23 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Counterpoint Mutual Funds LLC lifted its position in shares of Oscar Health by 95.7% during the first quarter. Counterpoint Mutual Funds LLC now owns 48,994 shares of the company’s stock worth $729,000 after purchasing an additional 23,960 shares during the last quarter. Gunderson Capital Management Inc. lifted its position in shares of Oscar Health by 37.4% during the first quarter. Gunderson Capital Management Inc. now owns 244,299 shares of the company’s stock worth $3,633,000 after purchasing an additional 66,466 shares during the last quarter. Nomura Holdings Inc. bought a new stake in shares of Oscar Health during the fourth quarter worth $179,000. Vanguard Group Inc. lifted its position in shares of Oscar Health by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 14,244,912 shares of the company’s stock worth $130,341,000 after purchasing an additional 116,978 shares during the last quarter. Finally, American International Group Inc. lifted its position in shares of Oscar Health by 1.6% during the fourth quarter. American International Group Inc. now owns 78,402 shares of the company’s stock worth $717,000 after purchasing an additional 1,199 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.